Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0001827672-23-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-21 | 2023-03-17+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $12.96 | -1,536 | 11.5K | -12% | -$19.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | S | D | 741 | $12.61 | 10,722 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-17 | S | D | 795 | $13.28 | 11,463 | D | — | — |